Gevo, Inc. (GEVO) Posts Q3 Loss of $0.48, Sales Top Expectations
Tweet
Share
E-mailGet Alerts GEVO Hot Sheet
Join SI Premium – FREE
Gevo, Inc. (NASDAQ: GEVO) reported Q3 EPS of ($0.48), $0.08 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $15.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Praj and Gevo sign Bio-IBA commercialization deal for India
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
